Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 20, 2017 07:30 ET | Source: Ocera Therapeutics, Inc.

Ocera Presents Three Posters and an Oral Presentation on OCR-002 at the AASLD Liver Meeting®

REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., Oct. 20, 2017 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (NASDAQ:OCRX), today announced that clinical study findings of OCR-002 (ornithine...
July 15, 2013 12:04 ET | Source: Ocera Therapeutics, Inc.

Ocera Therapeutics Announces Completion of Merger With Tranzyme

SAN DIEGO, July 15, 2013 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. ("Ocera"), a clinical stage biopharmaceutical company developing novel therapeutics for orphan liver diseases, and Tranzyme, Inc....